NO20064463L - Opioid leveringssystem - Google Patents

Opioid leveringssystem

Info

Publication number
NO20064463L
NO20064463L NO20064463A NO20064463A NO20064463L NO 20064463 L NO20064463 L NO 20064463L NO 20064463 A NO20064463 A NO 20064463A NO 20064463 A NO20064463 A NO 20064463A NO 20064463 L NO20064463 L NO 20064463L
Authority
NO
Norway
Prior art keywords
formulation
opioid
delivery
drug
pulmonary
Prior art date
Application number
NO20064463A
Other languages
English (en)
Norwegian (no)
Inventor
Steven L Shafer
Diana Helen Pliura
Orlando Richardo Hung
Original Assignee
Delex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/788,466 external-priority patent/US7648981B2/en
Priority claimed from PCT/CA2004/000303 external-priority patent/WO2004075879A1/en
Application filed by Delex Therapeutics Inc filed Critical Delex Therapeutics Inc
Publication of NO20064463L publication Critical patent/NO20064463L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20064463A 2003-02-28 2006-10-02 Opioid leveringssystem NO20064463L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45033303P 2003-02-28 2003-02-28
US10/788,466 US7648981B2 (en) 2003-02-28 2004-03-01 Opioid delivery system
PCT/CA2004/000303 WO2004075879A1 (en) 2003-02-28 2004-03-01 Opioid delivery system
PCT/CA2004/001578 WO2005082369A1 (en) 2003-02-28 2004-08-27 Opioid delivery system

Publications (1)

Publication Number Publication Date
NO20064463L true NO20064463L (no) 2006-11-30

Family

ID=42354335

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064463A NO20064463L (no) 2003-02-28 2006-10-02 Opioid leveringssystem

Country Status (6)

Country Link
EP (1) EP1732555A4 (de)
KR (1) KR20070011344A (de)
CN (1) CN1938027A (de)
AU (1) AU2004316339A1 (de)
NO (1) NO20064463L (de)
WO (1) WO2005082369A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029197A2 (de) * 2006-06-21 2009-03-04 Universität Bern System zur kontrolle der verabreichung von anästhesie
KR20220126409A (ko) 2021-03-09 2022-09-16 주식회사 퍼넥티브 비대면 영어 교육 플랫폼 및 외국어 학습방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
JP3911290B2 (ja) * 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
EP1392262A1 (de) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Verabreichung von arzneimittel-estern durch inhalation
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound

Also Published As

Publication number Publication date
EP1732555A4 (de) 2008-07-16
AU2004316339A1 (en) 2005-09-09
WO2005082369A1 (en) 2005-09-09
CN1938027A (zh) 2007-03-28
KR20070011344A (ko) 2007-01-24
EP1732555A1 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
WO2006023989A3 (en) Gas delivery and monitoring system
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
WO2006016953A3 (en) Bis closed loop anesthetic delivery
NO20052420L (no) Farmakologisk behandling av sovnapn±.
WO2007033050A3 (en) Synchronization of repetitive therapeutic interventions
ATE339954T1 (de) Kombinationen von formoterol und tiotropium-salz
PL363042A1 (en) Air in-line sensor for ambulatory drug infusion pump
WO2005061046A3 (en) Method and apparatus for modifying delivery of a therapy in response to onset of sleep
IL208184A0 (en) Glp-1, and methods for treating diabetes
NO20071505L (no) Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger.
WO2005044331A3 (en) Method and system of sensing a patient’s airflow
DK1458388T3 (da) En flydende farmaceutisk formulering omfattende nikotin til administrering i mundhulen
NO20065878L (no) Terapeutiske forbindelser
NO20065260L (no) Tri(cyklo)substituerte amidforbindelser
NO20064964L (no) Behandling av svekket respiratorisk funksjon
GEP20084567B (en) Carbostyril derivatives and mood stabilizers for treating mood disorders
CY1119580T1 (el) Νεα φαρμακα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας
IL176758A0 (en) 1,3-dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
NZ590839A (en) Treatment of pulmonary arterial hypertension
WO2006045314A3 (en) Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease
NO20064463L (no) Opioid leveringssystem
AU2003252182A8 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
CY1109215T1 (el) Συστημα χορηγησης οπιοειδους
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application